Beijing Lunarsun Pharmaceutical Co.,Ltd. was founded in 2006 and headquartered in Chaoyang District, Beijing. The company is a high-tech enterprise recognized by Beijing Science and Technology Commission. The company's main business areas are chemical generic drugs, apis, intermediates import and export registration and distribution, generic drug preparation research and development, MAH model production and sales, pharmaceutical apis, intermediates, basic chemicals, agricultural chemicals and other export trade.
At present, the company has formed long-term and stable cooperation with a number of domestic and foreign well-known pharmaceutical enterprises in the research and development of chemical generic drugs, outsourcing production, domestic and foreign API and preparation registration, market agent marketing. Since 2013, the company has abandoned its own production and factory operations to focus on research and development and marketing.

Our company has rich experience in the quality research of apis, the application and registration of domestic apis + preparations, the international registration of apis (DMF and document registration), the import registration of apis, and the domestic and international promotion of apis and intermediates. The company has declared and transferred more than 100 drug certificates (including import certificates).

In the field of pharmaceutical marketing, our company has set up a joint venture company in Tibet Autonomous Region specializing in pharmaceutical sales. The company is operated by a team with more than 20 years of experience in pharmaceutical sales in China, and has successfully operated more than a dozen products in the national market.

A wholly-owned subsidiary, Beijing Saintsun Pharma Co., Ltd., mainly engaged in the export business of pharmaceutical and chemical products; Chongqing Saintsun Pharma Co., Ltd., a wholly-owned subsidiary, was established in 2019 to undertake our generic drug research and development, MAH production management, and drug sales management business.